老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Calliditas Therapeutics AB

40.00
0.0000
成交量：- -
成交額：- -
市值：10.81億
市盈率：-23.69
高：40.00
開：40.00
低：40.00
收：40.00
52周最高：40.00
52周最低：40.00
股本：2,701.67萬
流通股本：1,590.95萬
量比：- -
換手率：- -
股息：- -
股息率：- -
每股收益(TTM):-1.6887
每股收益(LYR):-1.7274
淨資產收益率：-157.20%
總資產收益率：-13.41%
市淨率：95.06
市盈率(LYR):-23.16

資料載入中...

總覽公司新聞公告
2022/01/14

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/27

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/01/26

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/11/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/12

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/04

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/04

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/06/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/01

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/14

招股説明書

F-1 - Registration statement for certain foreign private issuers